chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I started with heavy coughing and body aches, sore throat and very tired and a spiked temperature. I got some home kits and tested. The test positive for COVID-19. At this point I called my doctor and told them about my test and I was given Paxlovid. I took the medication I started to recover. About a week later I had a temperature and I started having symptoms again. I tested again after 6 days, and it was negative. I stayed home for some extra time. I have symptoms still and I am more than 20 days out from my last positive test ready. I am still coughing, with a sore throat a few weeks later.
Pt recvd vax 18AUG91 & approx 7-10 days later exp fever, myalgia, arthralgia, h/a, & lt upper quad pain; 4 days later pt to MD w/sinus drainage & a hacking cough; Hospitalized & placed on Zinacef for poss sinusitis & pneumonitis;
severe depression; anxiety; hallucinating after 30-40 minutes; This spontaneous case was reported by a consumer and describes the occurrence of HALLUCINATION (hallucinating after 30-40 minutes) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017F21A and 004F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 26-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Oct-2021, the patient experienced HALLUCINATION (hallucinating after 30-40 minutes) (seriousness criterion medically significant). On an unknown date, the patient experienced DEPRESSION (severe depression) and ANXIETY (anxiety). At the time of the report, HALLUCINATION (hallucinating after 30-40 minutes) outcome was unknown and DEPRESSION (severe depression) and ANXIETY (anxiety) had not resolved.            Patient had seeing people go past her window. At store, she saw one of her aunties who passed away. No concomitant medications were provided by the reporter. No treatment information was provided by the reporter. Company Comment : This case concerns a 52-year-old, female patient with no relevant medical history, who experienced the unexpected serious event of hallucination and non serious events of depression and anxiety. The event of hallucination occurred on the same day 30-40 minutes after the second dose of mRNA-1273, while the other events occurred on an unknown date after second dose. The rechallenge was not applicable as events occurred after second dose and no further dosing was reported or planned, based on information provided. The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This case concerns a 52-year-old, female patient with no relevant medical history, who experienced the unexpected serious event of hallucination and non serious events of depression and anxiety. The event of hallucination occurred on the same day 30-40 minutes after the second dose of mRNA-1273, while the other events occurred on an unknown date after second dose. The rechallenge was not applicable as events occurred after second dose and no further dosing was reported or planned, based on information provided. The benefit-risk relationship of mRNA-1273 is not affected by this report.
nausea; Headache; fever; chills; body aches; This is a spontaneous report from a contactable Nurse (patient). A 42-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number E12573C) , intramuscular in Left arm on 21Dec2020 at 19:00 at single dose for COVID-19 immunization. Medical history included COVID-19 (the patient diagnosed with COVID-19 prior to vaccination); since the vaccination, the patient has not been tested for COVID-19. No known allergies to medications, food or other products.Concomitant medication included cetirizine hydrochloride (ZYRTEC) and ibuprofen, received within 2 weeks of vaccination. On 22Dec2020 at 17:00, the patient experienced nausea, headache, fever, chills and body aches, all non serious. No treatment was given and patient recovered from all the events in Dec2020.
Information has been received from a health professional concerning a 10 year old female with no known medical history or allergies who on 30-APR-1999 was vaccinated with a dose of Varivax (lot # 629257/1851H). Concomitant therapy included Zyrtec and montelukast sodium (MSD). On 04-JUN-2006 the patient developed a fever and rash after being exposed to someone with a shingles infection three weeks ago. There were several lesions but the reporter did not think there were 50 or more. Unspecified medical attention was sought. No laboratory diagnostic tests were performed. The patient's outcome was recovered. There was no product quality complaint involved. Additional information is not expected.
Patient is a 77y.o. year old  female with a history of pulmonary fibrosis who initially presented to the hospital on 12/18/21 with chest pain, shortness of breath, and syncope. SARS CoV 2 by NAA was negative at presentation. She is normally on home oxygen 2 L NC. She was admitted to the hospital with the diagnosis of NSTEMI, acute on chronic diastolic heart failure, AKI, syncope. On 1/8, her roommate tested positive for Covid 19, and the patient was tested secondary to her exposure, and her test was positive as well. Of note, the patient is fully vaccinated (Moderna x 2), although she had not received a booster. At present, the patient states that her breathing feels comfortable and essentially unchanged from yesterday, if not slightly better. On review of her vitals since presentation, it appears that her O2 requirements have been fluctuating from as low is 3 L NC, up to as high as HFNC at 95% O2. Most recently, it appears that she was on approximately 7 L NC, but was bumped to 15 L NC early this a.m., followed by a switch to HFNC FiO2 0.95, 60 L/m with an O2 sat in the upper 90s. ID is consulted regarding the above scenario. Her husband was at bedside, and we had a long discussion regarding the above situation. That discussion included several of her children who were on a conference call.
Rash on hands, feet, arms. Covid-19 arm. Hives. Itchy. - rash mostly gone, but hands still sensitive and hives comes back when in contact with warm water when washing dishes.
Patient comes in after 10 days with a rash to the right side of his body. Rash is light no itching or pain.
At approximately 11:31 am, patient complaint of "bumps" at right arm (9 minutes post Moderna booster vaccination).  This RN assessed patient and noted slight pinkness to right arm, patient denied pruritus, no complaints of difficulty breathing or shortness of breath noted and patient appeared to be in no apparent distress.  Respirations 18, pulse rate of 76, 99% spo2 on room, respirations even and unlabored.  Benadryl 25 mg oral tablet was given prophylactically at 11:35 am and advised patient to remain an additional 15 minutes for observation.  At approximately 11:48 am patient condition improved, she denied any pain and was in no apparent distress.  Respirations, pulse rate and oxygen saturation remain stable at 18, 78, and 99% respectively.  Patient was discharged home with husband at 11:54 am.
Within 15-minutes of vaccination, the patient reported dizziness, nausea, and chest pain. EMS evaluated the patient on-site. Patient was found to have orthostatic hypotension, hypoglycemia, and was near-syncopal. EMS administered 400mL of normal saline and 15g oral glucose.  EMS transported the patient to  Emergency Department. In the ED, the patient was hypertensive (163/73). EKG demonstrated NSR, rate 67 bpm, no ST-T changes, no ectopy, normal PR & QRS intervals. CBC/CMP was unremarkable. Patient noted improvement and was discharged with a diagnosis of a probable vasovagal event.
7 hrs after vaccination had headache, neck and back ache, body aches, right knee aching, rhinitis and urinary frequency lasted about 60 hours. Self treated with Aleve.
Felt immediate dizziness when I was finished with the shot.  This lasted for about a half hour.  No symptoms the following day.  March 25th felt tired and had back headache but have been having on and off dizziness and nausea for the last week.  it comes in spurts where i will feel fine but then it comes back.  Head feels heavy.
8 minutes following administration, patient stated she was feeling dizzy and nauseated. We sat with her and offered a cold bottle of water as a cold compress for her forehead, and she took several small sips of water. Within minutes her symptoms resolved completely, and she contacted a friend to drive her home. I followed up with the patient 2 hours post-vaccine and she stated that her symptoms had resolved entirely.
I had a huge uptick in the # of Raynauds attacks in the weeks following the vaccine, resulting in my fingers and toes going white and then blue, purple.  While I have always had Raynauds or at least have been diagnosed since high school, 2021 was far worse than any other year.  Furthermore, these attacks continued to get worse following the 2nd and 3rd shot despite being Spring and Summer when I rarely if ever get Raynauds attacks..  Secondly, I would have spurts of losing feeling in my arms and legs and almost feeling paralyzed.  The worse time of day was in the morning when I would wake up and actually have zero feeling in my arms and legs and having to wait minutes for feeling to come back in order to peel myself out of bed.
Severe pain to left arm unrelieved with narcotic pain med. Seen in office, xrays of clavicle humerus and forearm done-negative. To ER on 12-14-15 again with pain to left arm. US Doppler done to left arm-negative. Labs done. Inflammatory markers negative. Referred to neurologist and pain clinic.
This spontaneous report was received from a physician and refers to a 6 month-old patient of unknown gender. No information was provided regarding the patient's pertinent medical history, concomitant medications, drug reactions or allergies. On 30-MAY-2017, the patient was vaccinated with improperly stored dose of PEDVAXHIB (exact dose, dose number, route of administration were not reported; lot# reported as N00236 with the expiration date of 24-OCT-2019) for prophylaxis. The administered dose of PEDVAXHIB underwent multiple temperature excursion between 49 and 54 Fahrenheit degrees, which lasted for 16 hours, since 19-MAY-2017. Digital data logger was not involved to capture the temperature excursions. There were no previous temperature excursions reported. No adverse effects were reported. This is one of several reports received from the same reporter.
chills and continuously cold,  exhausted for weeks, on Monday May 10th woke up with  dizziness, heart palpitations and confusion
other vaccine same date on 21Apr2021; after the second shot, I had a herpes cold soar flare up; This is a spontaneous report from a contactable consumer (patient). A 52-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: was not reported), via an unspecified route of administration on 21Apr2021 12:00 (age at the time of vaccination 52-years-old), as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient had no known allergies. On 21Apr2021, the patient took other vaccine same date (name unspecified). Patient previously received first dose of BNT162B2 vaccine, on an unspecified date, as a single dose for COVID-19 immunization. On 22Apr2021 12:00, the patient experienced after the second shot, I had a herpes cold soar flare up, and on an unspecified date other vaccine same date on 21Apr2021. Patient received treatment as a result of adverse event which included Valtrex pill. No covid prior vaccination. No covid tested post vaccination. The outcome of the event after the second shot, I had a herpes cold soar flare up was recovered on an unspecified date; and other was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Injection given 3-20-09 AM.  Seen in office 3/23/09 with 3"x31/2" erythematous, swollen, warm induration @ site of Td injection.
I got shingles; it broke out on my calf. It was like a cluster of blisters. I went to the doctor where I was put on an antiviral. It began spreading up my leg but did not hurt. This was my first incident of shingles. On July 5th, I woke up with and earache and headache. I had a bump behind my ear. I went to the doctor where they treated me with steroids and an antibiotic because they thought I was a bug bite. It got worse and my doctor said it was shingles. I was treated with gabapentin, but it did not do well with me. It was very painful I had bumps in my scalp and body. I currently still have nerve pain that comes and goes. It is getting better but I know it's there.
Starting at 12:30 the day after I got the shot  (4/7), I started to have a headache, extreme tiredness and slight fever (101). Within the next hour my skin was sensitive to the touch, my joint ached - tired and headache continued. Walking was slow and I had a "drunk" feeling when standing. I woke up in the middle of the night drenched in sweat. *Side note, my period started on 4/8 so that could have contributed to some of the tired. Woke the next morning still feeling tired but most other symptoms had passed by 11am on 4/9.  My arm turned red, warm, tight, and itchy at the injection spot on Friday morning (4/9) and has stayed that way - current time of typing is 12:23, 4/10. All other symptoms have passed.
5 hours after receiving my second dose of Pfizer vaccine, my left shoulder and neck was severely swollen. I had many swollen lymph nodes and 1 in my neck was hard as a rock. It was painful to the touch. I also had a swollen lymph node under my left armpit.
Headache, ,sore injection site, stiff neck/pain , sore quadricept muscles, chills, fever, tiredness all on Day 2 after injection. Day 3 is fine - like it never happened.  I took ALOT of Tylenol and it really helped.
Patient administered moderna covid vaccine while temperature excursion was ongoing; Patient administered moderna covid vaccine while temperature excursion was ongoing; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patient administered moderna covid vaccine while temperature excursion was ongoing) and POOR QUALITY PRODUCT ADMINISTERED (Patient administered moderna covid vaccine while temperature excursion was ongoing) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patient administered moderna covid vaccine while temperature excursion was ongoing) and POOR QUALITY PRODUCT ADMINISTERED (Patient administered moderna covid vaccine while temperature excursion was ongoing). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patient administered moderna covid vaccine while temperature excursion was ongoing) and POOR QUALITY PRODUCT ADMINISTERED (Patient administered moderna covid vaccine while temperature excursion was ongoing) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported.  No treatment medication were reported.
Vaccine went into 2 to 8 degree Celsius in thaw state on or about 20 Dec 2021; Received its 30-days Exp date; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received its 30-days Exp date) and PRODUCT STORAGE ERROR (Vaccine went into 2 to 8 degree Celsius in thaw state on or about 20 Dec 2021) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2022 at 12:29 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 28-Jan-2022 at 12:29 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received its 30-days Exp date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2 to 8 degree Celsius in thaw state on or about 20 Dec 2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received its 30-days Exp date) and PRODUCT STORAGE ERROR (Vaccine went into 2 to 8 degree Celsius in thaw state on or about 20 Dec 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product reported by reporter. Vaccine went into 2 to 8 degree Celsius in thaw state on or about 20 Dec 2021. No treatment medication reported by reporter.
redness on her arm; itching; coughing; sneezing; felt sick; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 07-Mar-2021 and was forwarded to Moderna on 07-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness on her arm), PRURITUS (itching), COUGH (coughing), SNEEZING (sneezing) and ILLNESS (felt sick) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included PHENOBARBITAL, MONTELUKAST, MULTI VITAMIN & MINERAL and ZIPRASIDONE for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced ERYTHEMA (redness on her arm), PRURITUS (itching), COUGH (coughing), SNEEZING (sneezing) and ILLNESS (felt sick). At the time of the report, ERYTHEMA (redness on her arm), PRURITUS (itching), COUGH (coughing), SNEEZING (sneezing) and ILLNESS (felt sick) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Local erythema and induration at injection site involving about 2/3 of right thigh, around DTAP injection. Treated on 4/26/01 by family NP with Augmentin. No fever or other systemic symptoms.
Red hives on my back, slightly raised, and very itchy , all over my back, thighs, arms, waist, armpits, neck, all over; Red hives on my back, slightly raised, and very itchy; Very itchy/red hives on my back, slightly raised, and very itchy , all over my back, thighs, arms, waist, armpits, neck, all over; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Red hives on my back, slightly raised, and very itchy , all over my back, thighs, arms, waist, armpits, neck, all over), RASH ERYTHEMATOUS (Very itchy/red hives on my back, slightly raised, and very itchy , all over my back, thighs, arms, waist, armpits, neck, all over) and PRURITUS (Red hives on my back, slightly raised, and very itchy) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, the patient experienced URTICARIA (Red hives on my back, slightly raised, and very itchy , all over my back, thighs, arms, waist, armpits, neck, all over) and PRURITUS (Red hives on my back, slightly raised, and very itchy). In 2021, the patient experienced RASH ERYTHEMATOUS (Very itchy/red hives on my back, slightly raised, and very itchy , all over my back, thighs, arms, waist, armpits, neck, all over). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for Hives, at an unspecified dose and frequency. At the time of the report, URTICARIA (Red hives on my back, slightly raised, and very itchy , all over my back, thighs, arms, waist, armpits, neck, all over), RASH ERYTHEMATOUS (Very itchy/red hives on my back, slightly raised, and very itchy , all over my back, thighs, arms, waist, armpits, neck, all over) and PRURITUS (Red hives on my back, slightly raised, and very itchy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported.  Patient reported hives after 4 to 5 days later after vaccination and it raised slightly and itchy it spreads all over on back, thighs, arms, waist, armpits, neck, all over. It takes 7 months to go away and no medicines taken by patient to treat. Doctor advised patient to take Zyrtec or Benadryl for itching. Patient taken second dose of vaccine on 17 May and still having hives and taking one Zyrtec a day and antihistamines.
Came to office 11/4/03. Febrile for 2 days. Rash for 3 days. Also strep pharyngitis. Diagnosis chicken pox.
Severe chest pain (similar to prior heart attack in Sep 2018, minus left arm tingling into finger tips) with significant shortness of breath; these events began on 6 Nov 21 (the 23 day after my 1st dose).   I received my first dose on 14 Oct 21 at facility. My second dose was scheduled for Thursday, 4 Nov 21. I did not make that appointment due to another medical priority at Hospital. On 6 Nov 21, I experienced severe chest pain and shortness of breath for several days before being admitted to the Emergency department. On 11 Nov 21, my wife and I were discharged from Hospital. My discharge instructions included the following statement ?see your primary cardiologist to have cardiac MRI performed to better evaluate for possible vaccine induced myocarditis?.
STARTED TO FEEL HOT; BODY ACHES; CHILLS; HEADACHE; FEVER; This spontaneous report received from a patient concerned an adult female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 05-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 05-APR-2021, the subject experienced started to feel hot. On 05-APR-2021, the subject experienced body aches. On 05-APR-2021, the subject experienced chills. On 05-APR-2021, the subject experienced headache. On 05-APR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, fever, chills, started to feel hot, and body aches. This report was non-serious.
adult given pediatric dose; adult given pediatric dose; This case was reported by a pharmacist via call center representative and described the occurrence of underdose in a adult patient who received HBV (Engerix B pediatric) for prophylaxis.   On 21st March 2022, the patient received Engerix B pediatric. On 21st March 2022, unknown after receiving Engerix B pediatric, the patient experienced underdose and adult use of a child product. On an unknown date, the outcome of the underdose and adult use of a child product were unknown.   Additional Information: GSK Receipt Date: 24-Mar-2022 Reporter's Comments: The reporter did not have patient's demographic details. The reporter stated that, an adult patient was given pediatric dose of Engerix B. The reporter did not have lot number neither expiration date. The reporter consented to follow up by fax. Additional Supportive Information: The patient was given pediatric dose of Engerix B, which led to underdose and adult use of a child product. This was 1 of 3 cases reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR054853:Same reporter US-GLAXOSMITHKLINE-US2022AMR054854:Same reporter